Ritter Daniher Financial Advisory LLC DE Sells 71 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ritter Daniher Financial Advisory LLC DE cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 382 shares of the medical equipment provider’s stock after selling 71 shares during the period. Ritter Daniher Financial Advisory LLC DE’s holdings in Intuitive Surgical were worth $199,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $25,000. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth $28,000. Finally, Summit Securities Group LLC bought a new position in Intuitive Surgical in the 4th quarter worth $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 8.7 %

Shares of ISRG opened at $451.58 on Friday. The firm has a fifty day moving average price of $545.18 and a 200-day moving average price of $532.64. The firm has a market capitalization of $160.84 billion, a P/E ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.